Source:http://linkedlifedata.com/resource/pubmed/id/20842669
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2010-10-19
|
pubmed:abstractText |
The FAS receptor/ligand system is a key regulator of apoptotic cell death and corruption of this signaling pathway has been shown to participate in carcinogenesis. Functional polymorphisms in the FAS (FAS -1377G/A) and FASL (FASL -844T/C) genes alter their transcriptional activity. Therefore, we examined the association between these polymorphisms and the risk of developing nasopharyngeal carcinoma (NPC). FAS -1377G/A and FASL -844T/C genotypes were determined by PCR-based RFLP analysis in 582 patients with NPC and 613 frequency-matched controls. We observed a significantly increased risk of NPC associated with the FAS -1377AA genotype [odds ratio (OR)?=?1.69, 95% confidence interval (CI)?=?1.21-2.35] compared with the FAS -1377 GG genotype. In addition, elevated NPC risk was also found among subjects carrying both FAS -1377AA and FASL -844CC genotypes compared with both FAS -1377GG and FASL -844CT or -844TT, the OR was 2.39 (95% CI?=?1.50-3.79). After stratification by smoking status, heavy smokers (?15 pack-years) carrying FAS -1377AA genotype had an increased risk of NPC compared with FAS -1377GG genotype (OR?=?3.48, 95% CI?=?1.66-7.30). Furthermore, we observed a statistically significant interaction between the two polymorphisms and heavy smoking status (OR?=?5.92, 95% CI?=?1.91-18.3). Our study provides the first evidence that functional FAS -1377 G/A and FASL -844 T/C polymorphisms are associated with the risk of NPC, and this association is especially noteworthy in tobacco smokers.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-2744
|
pubmed:author | |
pubmed:copyrightInfo |
© 2010 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
944-50
|
pubmed:meshHeading |
pubmed-meshheading:20842669-Antigens, CD95,
pubmed-meshheading:20842669-Case-Control Studies,
pubmed-meshheading:20842669-China,
pubmed-meshheading:20842669-Fas Ligand Protein,
pubmed-meshheading:20842669-Female,
pubmed-meshheading:20842669-Genotype,
pubmed-meshheading:20842669-Humans,
pubmed-meshheading:20842669-Male,
pubmed-meshheading:20842669-Middle Aged,
pubmed-meshheading:20842669-Nasopharyngeal Neoplasms,
pubmed-meshheading:20842669-Polymerase Chain Reaction,
pubmed-meshheading:20842669-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:20842669-Polymorphism, Single Nucleotide,
pubmed-meshheading:20842669-Prognosis,
pubmed-meshheading:20842669-Risk Factors,
pubmed-meshheading:20842669-Smoking
|
pubmed:year |
2010
|
pubmed:articleTitle |
Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
|
pubmed:affiliation |
Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|